Shabeeb, Z. A., Y. F. Faraj, B. A. Mtashar, M. S. Hussein, and A. F. Hasan. “Immune-Biomarker Signature Predicts Early Molecular Response in Iraqi Chronic Myeloid Leukemia Patients Receiving Front-Line Tyrosine-Kinase Inhibitors”. Regulatory Mechanisms in Biosystems 16, no. 4 (December 2, 2025): e25197. Accessed June 24, 2026. https://medicine.dp.ua/index.php/med/article/view/1469.